benefits of glp 1 agonists Frontiers Discover the Game-Changing Benefits of

KFFs report notes an increase in spending on GLP-1 drugs in Medicaid programs starting in 2021

doi: 10.1016/j.exger.2017.12.005 184 SmithaJ

Epidemiology and pathophysiology of heart failure As one of the most prevalent consequences of CVD and other cardiometabolic conditions such as diabetes and hypertension, HF remains associated with high mortality rates (Bragazzi et al., 2021)

It also improved muscle function and body composition

Gut Health: A healthy and diverse gut microbiome is essential for optimal L-cell function

Companies that sell compounded medications should disclose that these drugs are not FDA-approved and haven't undergone the same rigorous testing for safety and effectiveness as FDA-approved drugs